StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
381
This month
2
This year
24
Publishing Date
2024 - 02 - 14
4
2023 - 12 - 01
4
2023 - 10 - 25
3
2023 - 05 - 18
2
2023 - 05 - 15
2
2023 - 04 - 28
3
2023 - 04 - 25
4
2023 - 03 - 30
2
2023 - 03 - 23
2
2023 - 03 - 16
2
2023 - 03 - 14
2
2023 - 03 - 08
3
2023 - 02 - 06
2
2022 - 12 - 22
2
2022 - 12 - 06
2
2022 - 11 - 30
3
2022 - 11 - 02
2
2022 - 10 - 26
3
2022 - 10 - 17
2
2022 - 09 - 28
2
2022 - 09 - 27
2
2022 - 09 - 19
3
2022 - 09 - 16
2
2022 - 08 - 03
2
2022 - 07 - 26
2
2022 - 07 - 15
4
2022 - 07 - 08
3
2022 - 06 - 03
3
2022 - 05 - 09
2
2022 - 05 - 02
2
2022 - 04 - 27
2
2022 - 03 - 16
3
2022 - 03 - 14
3
2022 - 03 - 07
3
2022 - 03 - 05
2
2022 - 03 - 04
4
2022 - 01 - 27
2
2021 - 12 - 17
2
2021 - 12 - 16
2
2021 - 11 - 16
2
2021 - 11 - 11
2
2021 - 10 - 13
2
2021 - 09 - 21
2
2021 - 09 - 20
2
2021 - 09 - 09
3
2021 - 07 - 29
3
2021 - 07 - 08
3
2021 - 06 - 29
2
2021 - 06 - 17
3
2021 - 06 - 10
2
2021 - 06 - 07
2
2021 - 05 - 12
2
2021 - 04 - 28
3
2021 - 04 - 20
2
2021 - 04 - 19
2
2021 - 04 - 09
4
2021 - 02 - 11
3
2021 - 02 - 10
2
2021 - 02 - 04
2
2021 - 01 - 08
2
Sector
Commercial services
2
Communications
2
Consumer non-durables
3
Consumer services
1
Distribution services
1
Electronic technology
8
Energy minerals
1
Finance
4
Health services
4
Health technology
381
Information
4
Manufacturing
23
N/a
8
Process industries
1
Producer manufacturing
7
Professional, scientific, and technical services
4
Retail trade
8
Technology services
12
Utilities
2
Tags
Aduhelm
6
Alliances
12
Alzheimer
24
Alzheimer's
45
Alzheimer's disease
20
Alzheimer’s
37
America
10
Antibody
9
Application
23
Approval
20
Biomarkers
7
Biosimilar
12
Biotech
6
Cancer
6
Collaboration
12
Conference
12
Depression
7
Disease
74
Drug
28
Europe
11
Events
7
Fda
32
Financial
6
Genetic
6
Genetown
24
Global
24
Grants
8
Growing
9
Growth
36
Health
6
International
6
Lecanemab
35
Leqembi
6
License
16
Market
73
Meeting
6
Multiple sclerosis
10
N/a
264
Neurological
6
People
20
Phase 2
13
Phase 2b
6
Phase 3
12
Pipeline
7
Positive
13
Potential
15
Rare
7
Report
18
Research
34
Results
24
Review
9
Sclerosis
16
Study
14
Submission
12
Technology
7
Therapeutics
52
Therapy
30
Topline
6
Treatment
41
Trial
13
Entities
3m company
261
Abbott laboratories
1784
Abbvie inc.
1022
Agilent technologies, inc.
429
Alphabet inc.
300
Amarin corporation plc
262
Amgen inc.
741
Astellas pharma inc
332
Astrazeneca plc
664
Bausch health companies inc.
389
Baxter international inc.
482
Becton, dickinson and company
796
Beigene, ltd.
323
Bio-rad laboratories, inc.
448
Biogen inc.
381
Biontech se
366
Boston scientific corporation
575
Brainsway ltd.
330
Bristol-myers squibb company
662
Danaher corporation
785
Eli lilly and company
1708
Exact sciences corporation
259
Genmab a/s
297
Gilead sciences, inc.
499
Glaxosmithkline plc
884
Hepion pharmaceuticals, inc.
403
Hologic, inc.
328
Illumina, inc.
451
Incyte corporation
444
Jaguar health, inc.
257
Johnson & johnson
4571
Koninklijke philips n.v.
962
Koninklijke philips nv
437
Medtronic plc
1284
Merck & company, inc.
336
Moderna, inc.
349
Morgan stanley
617
Morphosys ag
313
Nektar therapeutics
365
Novartis ag
1241
Novo nordisk a/s
631
Oncocyte corporation
481
Orange
489
Perkinelmer, inc.
274
Pfizer, inc.
692
Provention bio, inc.
348
Ptc therapeutics, inc.
265
Qiagen n.v.
369
Regeneron pharmaceuticals, inc.
419
Sanofi
4532
Stryker corporation
536
Sutro biopharma, inc.
270
Takeda pharmaceutical company limited
419
Teleflex incorporated
269
Teva pharmaceutical industries ltd
630
Therapeuticsmd, inc.
277
Thermo fisher scientific inc
1621
Tonix pharmaceuticals holding corp.
267
Vaxart, inc.
313
Viatris inc.
364
Symbols
AAPL
4
ABBV
37
ABEO
7
ABSI
4
ABT
8
ADAP
7
ALKS
5
ALNY
5
ALPMF
11
ALPMY
11
AMGN
49
AMRN
3
ARAV
3
AZN
22
AZNCF
20
BABA
6
BAX
11
BCLI
5
BHC
7
BIIB
381
BLUE
3
BMY
11
CIEN
3
CYDY
4
DNLI
14
DRRX
3
EDIT
3
EMKR
3
GBIO
7
GIFLF
4
GIKLY
4
GILD
6
GLAXF
23
GLPG
4
GLPGF
4
GSK
24
INCY
4
INTC
6
IONS
23
IOVA
4
JAZZ
4
JNJ
29
KMDA
4
LLY
20
LMT
6
MSFT
6
NOK
6
NVIV
4
NVO
7
NVS
54
NVSEF
47
ORTX
8
REGN
4
SAGE
20
SNY
53
SNYNF
48
TAK
6
TEVJF
28
TMO
7
VTRS
15
Exchanges
Amex
3
Nasdaq
381
Nyse
126
Crawled Date
2024 - 02 - 14
4
2023 - 12 - 01
4
2023 - 10 - 25
3
2023 - 05 - 15
2
2023 - 04 - 28
3
2023 - 04 - 25
4
2023 - 03 - 31
2
2023 - 03 - 23
2
2023 - 03 - 16
2
2023 - 03 - 14
2
2023 - 03 - 08
3
2023 - 03 - 06
2
2023 - 02 - 06
2
2022 - 12 - 09
2
2022 - 12 - 06
2
2022 - 11 - 30
3
2022 - 11 - 02
2
2022 - 10 - 26
3
2022 - 10 - 17
2
2022 - 09 - 28
3
2022 - 09 - 19
3
2022 - 09 - 16
2
2022 - 08 - 04
2
2022 - 07 - 26
2
2022 - 07 - 15
4
2022 - 07 - 08
3
2022 - 07 - 06
2
2022 - 06 - 03
3
2022 - 05 - 02
2
2022 - 04 - 27
2
2022 - 03 - 16
3
2022 - 03 - 14
2
2022 - 03 - 07
3
2022 - 03 - 05
3
2022 - 03 - 04
4
2021 - 12 - 17
2
2021 - 12 - 16
2
2021 - 11 - 16
2
2021 - 11 - 11
2
2021 - 10 - 18
2
2021 - 10 - 13
2
2021 - 09 - 28
2
2021 - 09 - 23
2
2021 - 09 - 21
2
2021 - 09 - 20
2
2021 - 09 - 09
3
2021 - 07 - 29
3
2021 - 07 - 08
3
2021 - 06 - 29
2
2021 - 06 - 17
3
2021 - 06 - 10
2
2021 - 06 - 07
2
2021 - 05 - 12
2
2021 - 04 - 28
3
2021 - 04 - 20
3
2021 - 04 - 09
4
2021 - 02 - 11
3
2021 - 02 - 10
2
2021 - 02 - 04
2
2021 - 01 - 08
2
Crawled Time
00:00
30
00:01
1
00:20
1
01:00
15
02:00
4
03:00
8
04:00
5
04:20
4
05:00
2
06:00
3
07:00
3
08:00
6
08:20
1
09:00
6
10:00
4
11:00
23
11:33
1
12:00
47
12:15
5
12:20
8
12:30
6
13:00
31
13:01
1
13:03
1
13:04
1
13:15
1
13:20
2
13:30
9
14:00
16
14:03
2
14:15
2
14:20
2
14:30
3
15:00
19
15:15
1
15:20
3
15:30
3
16:00
11
16:07
2
16:20
2
17:00
11
17:07
1
18:00
10
18:03
1
18:04
1
19:00
13
20:00
10
20:20
1
21:00
20
22:00
6
23:00
12
Source
investor.alkermes.com
2
ir.voyagertherapeutics.com
1
www.biospace.com
117
www.fda.gov
1
www.globenewswire.com
103
www.prnewswire.com
157
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
sector :
Health technology
entities :
Biogen inc.
save search
EISAI TO PRESENT DATA ON ROBUST NEUROLOGY PORTFOLIO AT THE 76th AMERICAN ACADEMY OF NEUROLOGY® (AAN) ANNUAL MEETING
Published:
2024-04-12
(Crawled : 12:00)
- prnewswire.com
BIIB
|
$192.13
-1.55%
-1.57%
1.3M
|
Health Technology
|
-3.46%
|
O:
1.03%
H:
0.49%
C:
-2.96%
neurology
meeting
Avalo Therapeutics Appoints Biotech Leaders to Board of Directors
Published:
2024-04-02
(Crawled : 12:00)
- globenewswire.com
AVTX
|
$13.9
-12.8%
-14.68%
130K
|
Manufacturing
|
-17.96%
|
O:
-22.8%
H:
15.52%
C:
1.07%
ICLR
|
$291.85
-0.74%
-0.75%
390K
|
Health Technology
|
-12.83%
|
O:
-2.95%
H:
0.0%
C:
-1.43%
BIIB
|
$192.13
-1.55%
-1.57%
1.3M
|
Health Technology
|
-9.44%
|
O:
-1.11%
H:
0.16%
C:
-2.56%
biotech
leaders
therapeutics
Eisai Completes Submission of LEQEMBI® (lecanemab-irmb) Supplemental Biologics License Application for IV Maintenance Dosing for the Treatment of Early Alzheimer's Disease to the U.S. FDA
Published:
2024-03-31
(Crawled : 00:00)
- prnewswire.com
BIIB
|
$192.13
-1.55%
-1.57%
1.3M
|
Health Technology
|
-10.23%
|
O:
-0.88%
H:
0.0%
C:
0.0%
leqembi
fda
disease
license
treatment
alzheimer's
application
submission
Dyne Therapeutics Announces CEO Transition
Published:
2024-03-25
(Crawled : 12:00)
- globenewswire.com
SNYNF
|
$92.116
-2.18%
2.3K
|
Health Technology
|
-1.71%
|
O:
-100.0%
H:
NaN%
C:
Infinity%
SNY
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
-4.58%
|
O:
0.42%
H:
0.0%
C:
0.0%
DYN
|
$24.78
0.61%
0.61%
760K
|
Health Technology
|
-12.78%
|
O:
-13.24%
H:
11.02%
C:
6.37%
BIIB
|
$192.13
-1.55%
-1.57%
1.3M
|
Health Technology
|
-10.52%
|
O:
-0.15%
H:
0.23%
C:
-0.5%
ceo
therapeutics
Pilates Equipment Market size to grow by USD 101.05 million from 2022 to 2027, North America to account for 37% of the growth, Technavio
Published:
2024-03-19
(Crawled : 21:00)
- prnewswire.com
BIIB
|
$192.13
-1.55%
-1.57%
1.3M
|
Health Technology
|
-10.74%
|
O:
-0.66%
H:
1.0%
C:
0.45%
america
million
market
Global Neutropenia Market Poised to Reach USD 5.86 Billion by 2028, Amid Rising Cancer Incidence and Advancements in Treatment Options
Published:
2024-03-18
(Crawled : 00:00)
- prnewswire.com
SNYNF
|
$92.116
-2.18%
2.3K
|
Health Technology
|
-2.92%
|
O:
-0.02%
H:
0.0%
C:
0.0%
BAX
|
$39.52
-0.13%
0.0%
2.8M
|
Health Technology
|
-4.74%
|
O:
0.02%
H:
1.03%
C:
0.96%
SNY
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
-4.5%
|
O:
-1.51%
H:
0.0%
C:
0.0%
GILD
|
$66.94
-0.55%
-0.55%
5.3M
|
Health Technology
|
-8.12%
|
O:
0.11%
H:
0.59%
C:
0.1%
BIIB
|
$192.13
-1.55%
-1.57%
1.3M
|
Health Technology
|
-11.05%
|
O:
-0.48%
H:
0.31%
C:
0.13%
reach
cancer
treatment
global
market
World Cancer Immunotherapy Market Research 2023-2027: Curing Cancer is Generating Enormous New Opportunities - Outcome Potential, Technology Environment, Target Solutions
Published:
2024-03-16
(Crawled : 04:20)
- prnewswire.com
BIIB
|
$192.13
-1.55%
-1.57%
1.3M
|
Health Technology
|
Email alert
Add to watchlist
SNY
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
Email alert
Add to watchlist
JNJ
|
$144.77
0.22%
-0.01%
9.3M
|
Health Technology
|
Email alert
Add to watchlist
SNYNF
|
$92.116
-2.18%
2.3K
|
Health Technology
|
Email alert
Add to watchlist
world
cancer
research
solutions
immunotherapy
technology
market
Amyotrophic Lateral Sclerosis Treatment Market size to grow by USD 663.7 million, 42% of market growth is expected in North America, Technavio
Published:
2024-03-12
(Crawled : 04:00)
- prnewswire.com
ELDN
|
$1.65
3.13%
3.03%
13K
|
Manufacturing
|
-7.51%
|
O:
1.73%
H:
1.7%
C:
-7.39%
SNY
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
-5.1%
|
O:
0.01%
H:
0.0%
C:
0.0%
DNLI
|
$16.81
-3.06%
-3.15%
1.4M
|
Health Technology
|
-20.06%
|
O:
-0.6%
H:
0.74%
C:
-3.66%
BCLI
|
$0.5419
2.81%
2.73%
530K
|
Health Technology
|
60.21%
|
O:
-2.43%
H:
2.8%
C:
-4.02%
BIIB
|
$192.13
-1.55%
-1.57%
1.3M
|
Health Technology
|
-15.18%
|
O:
-0.32%
H:
0.18%
C:
-0.86%
expected
sclerosis
treatment
growth
market
AbCellera to Collaborate with Biogen to Discover Therapeutic Antibodies for Neurological Conditions
Published:
2024-03-11
(Crawled : 17:00)
- biospace.com/
ABCL
|
$3.92
-3.21%
-3.32%
1.1M
|
|
-15.09%
|
O:
5.03%
H:
0.0%
C:
0.0%
BIIB
|
$192.13
-1.55%
-1.57%
1.3M
|
Health Technology
|
-12.58%
|
O:
0.03%
H:
3.1%
C:
3.03%
neurological
New Biomarker Data Add Further Evidence Supporting the Potential Benefit of SPINRAZA® (nusinersen) in Infants and Toddlers with Unmet Clinical Needs after Gene Therapy
Published:
2024-03-06
(Crawled : 12:30)
- globenewswire.com
IONS
|
$40.93
-1.47%
-1.49%
1.1M
|
Health Technology
|
-6.0%
|
O:
0.05%
H:
1.32%
C:
0.18%
BIIB
|
$192.13
-1.55%
-1.57%
1.3M
|
Health Technology
|
-10.16%
|
O:
0.11%
H:
1.16%
C:
0.04%
spinraza
biomarker
potential
therapy
Biogen Highlights New Data at the International Conference on Alzheimer’s and Parkinson’s Diseases (AD/PD™) 2024 Annual Meeting
Published:
2024-03-04
(Crawled : 21:00)
- globenewswire.com
BIIB
|
$192.13
-1.55%
-1.57%
1.3M
|
Health Technology
|
-11.7%
|
O:
-0.62%
H:
0.84%
C:
-1.1%
conference
alzheimer’s
international
meeting
parkinson’s
Amprion's αSyn Seed Amplification Assay (αS-SAA) Highlighted in 10 Presentations at AD/PD™ 2024 International Conference
Published:
2024-03-04
(Crawled : 19:00)
- prnewswire.com
BIIB
|
$192.13
-1.55%
-1.57%
1.3M
|
Health Technology
|
-11.7%
|
O:
-0.62%
H:
0.84%
C:
-1.1%
conference
international
Biogen’s QALSODY® (tofersen), the First Therapy to Treat Rare, Genetic Form of ALS, Received Positive Opinion from CHMP
Published:
2024-02-23
(Crawled : 12:00)
- globenewswire.com
IONS
|
$40.93
-1.47%
-1.49%
1.1M
|
Health Technology
|
-5.55%
|
O:
0.25%
H:
2.95%
C:
2.88%
BIIB
|
$192.13
-1.55%
-1.57%
1.3M
|
Health Technology
|
-12.28%
|
O:
0.43%
H:
1.06%
C:
-0.05%
qalsody
first
chmp
genetic
positive
treat
therapy
Biosimilar Lymphocyte Modulator Global Market Report 2024 - Robust 10.6% CAGR Forecast, Amid Rising Autoimmune Disease Prevalence
Published:
2024-02-20
(Crawled : 03:00)
- prnewswire.com
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
-6.46%
|
O:
2.81%
H:
0.0%
C:
-0.95%
NVS
|
$93.08
-0.13%
0.86%
1.2M
|
Health Technology
|
-7.36%
|
O:
2.91%
H:
0.35%
C:
-0.38%
BIIB
|
$192.13
-1.55%
-1.57%
1.3M
|
Health Technology
|
-10.92%
|
O:
-0.69%
H:
1.24%
C:
0.76%
disease
biosimilar
report
global
market
9.18% CAGR growth in Cancer Biologics Market by Product (Monoclonal antibodies, Cell and gene therapy, vaccines, and others), Route Of Administration, and Geography- Global forecast to 2028
Published:
2024-02-19
(Crawled : 16:00)
- prnewswire.com
BIIB
|
$192.13
-1.55%
-1.57%
1.3M
|
Health Technology
|
Email alert
Add to watchlist
VTRS
|
$11.095
-0.22%
-0.23%
6.1M
|
Health Technology
|
Email alert
Add to watchlist
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
Email alert
Add to watchlist
AZN
|
$68.53
0.39%
0.39%
3.7M
|
Health Technology
|
Email alert
Add to watchlist
GLAXF
|
$20.2
-14.18%
510
|
Health Technology
|
Email alert
Add to watchlist
GSK
|
$39.6
-0.88%
0.0%
2.8M
|
Health Technology
|
Email alert
Add to watchlist
AZNCF
|
$135.305
-4.19%
1.1K
|
Health Technology
|
Email alert
Add to watchlist
JAZZ
|
$107.15
-1.61%
-1.63%
590K
|
Health Technology
|
Email alert
Add to watchlist
NVS
|
$93.08
-0.13%
0.86%
1.2M
|
Health Technology
|
Email alert
Add to watchlist
AMGN
|
$264.07
-0.59%
-0.59%
2.2M
|
Health Technology
|
Email alert
Add to watchlist
cancer
cell
global
growth
market
Sage Therapeutics Announces Fourth Quarter and Full Year 2023 Financial Results and Highlights Pipeline and Business Progress
Published:
2024-02-14
(Crawled : 15:00)
- biospace.com/
SAGE
|
$12.585
-19.48%
-24.2%
4.3M
|
Health Technology
|
-32.1%
|
O:
9.69%
H:
8.48%
C:
1.98%
BIIB
|
$192.13
-1.55%
-1.57%
1.3M
|
Health Technology
|
-13.9%
|
O:
0.16%
H:
0.43%
C:
-2.76%
business
year
pipeline
therapeutics
financial
results
Biosimilar Hormones Global Market Report 2024 - Niche Sectors Record Notable Market Contributions
Published:
2024-02-14
(Crawled : 03:00)
- prnewswire.com
SNYNF
|
$92.116
-2.18%
2.3K
|
Health Technology
|
-0.92%
|
O:
-2.71%
H:
0.0%
C:
0.0%
LLY
|
$750.77
0.54%
-0.04%
3.1M
|
Health Technology
|
0.51%
|
O:
0.38%
H:
2.44%
C:
1.54%
SNY
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
-0.65%
|
O:
-1.1%
H:
0.0%
C:
0.0%
BIIB
|
$192.13
-1.55%
-1.57%
1.3M
|
Health Technology
|
-13.9%
|
O:
0.16%
H:
0.43%
C:
-2.76%
AMGN
|
$264.07
-0.59%
-0.59%
2.2M
|
Health Technology
|
-8.22%
|
O:
-0.21%
H:
0.34%
C:
0.07%
biosimilar
report
global
market
Protein Inhibitors Global Market Report 2024 - A $125 Billion Market in 2028, Registering Compound Annual Growth of 9%
Published:
2024-02-14
(Crawled : 02:00)
- prnewswire.com
LZAGF
|
$572.535
-19.1%
17
|
Health Technology
|
14.51%
|
O:
3.14%
H:
1.92%
C:
1.92%
GLAXF
|
$20.2
-14.18%
510
|
Health Technology
|
-3.81%
|
O:
-2.14%
H:
0.0%
C:
-0.63%
SNYNF
|
$92.116
-2.18%
2.3K
|
Health Technology
|
-0.92%
|
O:
-2.71%
H:
0.0%
C:
0.0%
AZNCF
|
$135.305
-4.19%
1.1K
|
Health Technology
|
9.56%
|
O:
0.87%
H:
0.21%
C:
-2.23%
LZAGY
|
$57.64
0.02%
36K
|
Professional, Scientific, and T...
|
16.09%
|
O:
4.07%
H:
1.53%
C:
1.45%
TMO
|
$547.25
-1.32%
-0.02%
1.6M
|
Health Technology
|
2.96%
|
O:
0.56%
H:
1.3%
C:
1.22%
TAK
|
$13.15
-0.61%
0.0%
1.6M
|
Health Technology
|
-7.74%
|
O:
0.42%
H:
1.04%
C:
0.97%
JNJ
|
$144.77
0.22%
-0.01%
9.3M
|
Health Technology
|
-8.4%
|
O:
-0.91%
H:
0.0%
C:
0.0%
GSK
|
$39.6
-0.88%
0.0%
2.8M
|
Health Technology
|
-3.48%
|
O:
0.89%
H:
0.41%
C:
0.1%
LLY
|
$750.77
0.54%
-0.04%
3.1M
|
Health Technology
|
0.51%
|
O:
0.38%
H:
2.44%
C:
1.54%
BAX
|
$39.52
-0.13%
0.0%
2.8M
|
Health Technology
|
-0.13%
|
O:
0.33%
H:
0.63%
C:
-0.28%
ABBV
|
$164.25
1.05%
-0.76%
4M
|
Health Technology
|
-6.83%
|
O:
-0.73%
H:
0.0%
C:
0.0%
ABT
|
$105.9
-3.03%
0.07%
12M
|
Health Technology
|
-2.99%
|
O:
-0.83%
H:
0.66%
C:
0.38%
SNY
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
-0.65%
|
O:
-1.1%
H:
0.0%
C:
0.0%
GLPG
|
$29.25
-0.81%
-0.82%
190K
|
Health Technology
|
-24.5%
|
O:
-1.72%
H:
1.8%
C:
1.59%
BIIB
|
$192.13
-1.55%
-1.57%
1.3M
|
Health Technology
|
-13.9%
|
O:
0.16%
H:
0.43%
C:
-2.76%
AZN
|
$68.53
0.39%
0.39%
3.7M
|
Health Technology
|
11.85%
|
O:
0.28%
H:
0.93%
C:
0.75%
AMGN
|
$264.07
-0.59%
-0.59%
2.2M
|
Health Technology
|
-8.22%
|
O:
-0.21%
H:
0.34%
C:
0.07%
report
global
protein
growth
market
Listeria Monocytogenes Infections Treatment Global Market Report 2024: Global Expansion in Listeria Monocytogenes Treatment Sector Predicted Amid Rising Foodborne Disease Incidence
Published:
2024-02-14
(Crawled : 00:00)
- prnewswire.com
GLAXF
|
$20.2
-14.18%
510
|
Health Technology
|
-3.81%
|
O:
-2.14%
H:
0.0%
C:
-0.63%
SNYNF
|
$92.116
-2.18%
2.3K
|
Health Technology
|
-0.92%
|
O:
-2.71%
H:
0.0%
C:
0.0%
AZNCF
|
$135.305
-4.19%
1.1K
|
Health Technology
|
9.56%
|
O:
0.87%
H:
0.21%
C:
-2.23%
GSK
|
$39.6
-0.88%
0.0%
2.8M
|
Health Technology
|
-3.48%
|
O:
0.89%
H:
0.41%
C:
0.1%
LLY
|
$750.77
0.54%
-0.04%
3.1M
|
Health Technology
|
0.51%
|
O:
0.38%
H:
2.44%
C:
1.54%
VRTX
|
$393.1
-0.27%
-0.27%
880K
|
Health Technology
|
-5.26%
|
O:
0.56%
H:
0.49%
C:
-0.12%
SNY
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
-0.65%
|
O:
-1.1%
H:
0.0%
C:
0.0%
BIIB
|
$192.13
-1.55%
-1.57%
1.3M
|
Health Technology
|
-13.9%
|
O:
0.16%
H:
0.43%
C:
-2.76%
AZN
|
$68.53
0.39%
0.39%
3.7M
|
Health Technology
|
11.85%
|
O:
0.28%
H:
0.93%
C:
0.75%
AMGN
|
$264.07
-0.59%
-0.59%
2.2M
|
Health Technology
|
-8.22%
|
O:
-0.21%
H:
0.34%
C:
0.07%
disease
report
treatment
expansion
global
infections
market
Checkpoint Inhibitors Market Forecast Reveals Impressive Growth With Focus on Novel Therapies and Regional Expansion
Published:
2024-02-12
(Crawled : 23:00)
- prnewswire.com
GLAXF
|
$20.2
-14.18%
510
|
Health Technology
|
-1.6%
|
O:
3.52%
H:
0.0%
C:
-1.18%
AZNCF
|
$135.305
-4.19%
1.1K
|
Health Technology
|
12.13%
|
O:
0.06%
H:
2.34%
C:
2.29%
ALPMY
|
$9.34
-1.11%
690K
|
Manufacturing
|
-13.68%
|
O:
0.37%
H:
0.74%
C:
0.28%
TAK
|
$13.15
-0.61%
0.0%
1.6M
|
Health Technology
|
-7.55%
|
O:
0.14%
H:
0.35%
C:
0.07%
NVS
|
$93.08
-0.13%
0.86%
1.2M
|
Health Technology
|
-7.67%
|
O:
-0.34%
H:
0.23%
C:
-1.13%
JNJ
|
$144.77
0.22%
-0.01%
9.3M
|
Health Technology
|
-7.76%
|
O:
0.7%
H:
0.0%
C:
0.0%
GSK
|
$39.6
-0.88%
0.0%
2.8M
|
Health Technology
|
-2.73%
|
O:
1.22%
H:
0.07%
C:
-0.43%
LLY
|
$750.77
0.54%
-0.04%
3.1M
|
Health Technology
|
1.29%
|
O:
-0.96%
H:
1.75%
C:
1.75%
BMY
|
$47.84
-0.87%
-0.02%
12M
|
Health Technology
|
-2.99%
|
O:
-0.18%
H:
0.48%
C:
-1.91%
ABBV
|
$164.25
1.05%
-0.76%
4M
|
Health Technology
|
-6.08%
|
O:
0.8%
H:
0.0%
C:
0.0%
ZLAB
|
$13.75
-4.65%
-4.87%
400K
|
Health Technology
|
-20.81%
|
O:
-1.15%
H:
1.03%
C:
-1.5%
VRTX
|
$393.1
-0.27%
-0.27%
880K
|
Health Technology
|
-5.82%
|
O:
-0.28%
H:
0.49%
C:
-0.32%
SNY
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
-0.71%
|
O:
-0.06%
H:
0.0%
C:
0.0%
IPHA
|
$2.35
-9.27%
-10.21%
16K
|
Health Technology
|
0.39%
|
O:
-3.1%
H:
1.2%
C:
-0.8%
INCY
|
$52.74
-0.9%
-0.91%
2.5M
|
Health Technology
|
-7.99%
|
O:
3.8%
H:
1.1%
C:
-1.17%
BIIB
|
$192.13
-1.55%
-1.57%
1.3M
|
Health Technology
|
-20.26%
|
O:
-3.72%
H:
0.58%
C:
-3.82%
AZN
|
$68.53
0.39%
0.39%
3.7M
|
Health Technology
|
11.16%
|
O:
-0.26%
H:
0.73%
C:
-0.36%
ARGX
|
$366.37
-1.16%
-1.18%
270K
|
Health Technology
|
-5.61%
|
O:
-2.3%
H:
1.65%
C:
0.83%
AMGN
|
$264.07
-0.59%
-0.59%
2.2M
|
Health Technology
|
-9.45%
|
O:
0.06%
H:
0.31%
C:
-1.4%
expansion
growth
market
← Previous
1
2
3
4
5
6
7
8
9
…
19
20
Next →
Gainers vs Losers
56%
44%
Top 10 Gainers
INVO
|
$1.76
131.58%
56.82%
230M
|
Health Technology
SINT
|
$0.0365
59.39%
37.26%
470M
|
Health Technology
WISA
4
|
$9.19
50.66%
33.7%
65M
|
Electronic Technology
EDBL
|
$6.73
47.91%
32.39%
13M
|
GCTK
|
$0.715
36.27%
26.62%
640K
|
Manufacturing
TCON
|
$2.33
36.26%
26.61%
2M
|
Health Technology
TIRX
|
$0.48
6.43%
24.58%
4.8M
|
KZIA
|
$0.38
30.58%
23.42%
300K
|
Health Technology
VNDA
|
$5.23
29.14%
22.56%
24M
|
Health Technology
ATNF
|
$1.91
29.05%
22.51%
310K
|
Your saved searches
Save your searches and get alerts when important news are released.